COMPANY PROFILE · UPDATED 18 NOV 2025

Locana

Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

locanabio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2016
Headcount: 103
Open roles: 0
Last raised: Series B · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Locana

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$155,550,000

Investors

Funding rounds

Series B
$100MDec 14, 2020
Series B
Vida Ventures, Temasek, Lightstone Ventures, RA Capital Management, SVB Leerink, Invus, GV, Acuta Capital Partners, Arch Venture Partners, UCB Ventures
$100MDec 13, 2020
Grant
$550KJun 12, 2019
Grant
Muscular Dystrophy Association
$550KJun 11, 2019
Series A
$55MMay 22, 2019
Series A
Arch Venture Partners, UCB Ventures, Lightstone Ventures, Temasek, GV
$55MMay 21, 2019

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Industries

Software Companies Medical Organizations Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Locana Headquarters Location

3545 John Hopkins Court suite 200, San Diego, CA, 92121

Loading map…